RopesTalk

Ropes & Gray LLP

500 episodes listed below

Listen to the show on

Legal risk, translated for organizational judgment.

The gist

RopesTalk brings legal and compliance conversations into the operating realities of employers, governance teams and business leaders. Its recent episodes move from AI workplace policies and ERISA litigation risk to cybersecurity psychology, toxic culture, integrated assurance and in-house counsel strategy.

PRESS PLAY

Find your next episode

All episodes

About RopesTalk

RopesTalk is a legal and compliance podcast for people who need to understand risk before it turns into a dispute, policy failure or governance problem. Its recent episodes are practical but not shallow. The show often begins with a legal or regulatory question, then follows it into the human and organizational behavior behind the issue. AI appears as a recurring pressure point. Episodes consider why employers need clear AI policies, where generative AI may create employment-law exposure, and why workplace investigations still depend on human judgment. The show is especially careful about distinctions. Using AI for background research is treated differently from relying on it in hiring, promotion, discipline or termination decisions. Benefits litigation receives the same close treatment. A discussion of voluntary benefit plans looks at ERISA class actions involving accident insurance, critical illness coverage and hospital indemnity benefits, with attention to fiduciary breaches, prohibited transactions and broker or consultant exposure. Culture is another central concern. The Culture & Compliance Chronicles episodes frame compliance as a living workplace pattern, shaped by trust, training, curiosity and the ability to make abstract obligations feel real. Conversations connect ethics programs to play, creativity, cybersecurity psychology, emerging crime, social engineering and integrated assurance. The show also steps inside the legal function itself. In-house counsel conversations ask how general counsel and compliance leaders build trust with the business, stay in the room for key decisions and turn governance into commercial support rather than a late-stage obstacle. RopesTalk is measured, lawyerly and people-aware. It does not chase drama. Its strength is translating complex legal developments into questions leaders can actually ask inside an organization: who owns the decision, what policy governs it, where does liability attach and what cultural pattern is being reinforced.

Made for: RopesTalk is for legal, compliance, HR, governance, benefits and risk professionals who need current legal issues connected to workplace decisions. It also suits business leaders who work closely with counsel on AI use, culture, employment policy and fiduciary risk.

What sets it apart: The show pairs legal specificity with a sustained interest in culture and human behavior. Similar podcasts may summarize developments; RopesTalk more often asks how a policy, decision or training choice will function inside an organization.

In their own words

Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.

As heard by us

Based on 5 episodes we listened to · September 2026

RopesTalk turns compliance risks into concrete questions about policies, incentives, reporting systems, technology, and the judgment required to make them work.

RopesTalk treats compliance as an operating problem with human consequences. Through interviews and lawyer-led discussions, it moves among whistleblowing, social engineering, supply-chain labor conditions, legal technology, and workplace AI policy.

Read our full review in PlayNext →

Why you'd press play

Wirecard whistleblowing meets AI hiring policy, so your risk radar watches people, not just paperwork.

Press play if you want

  • practical guidance for raising concerns without turning your inbox into Exhibit A
  • cybersecurity explained through the psychological tricks that make ordinary requests suddenly dangerous
Read the full recommendation in PlayNext →
AI workplace policiesemployment law riskcompliance culturecybersecurity psychologyERISA fiduciary litigationvoluntary benefits lawsuitsintegrated assurancein-house legal strategy

Talks about

Best episodes of RopesTalk

Short reviews from the PlayNext desk, based on the episodes we processed.

AI at Work – Drafting an Effective and Compliant AI Workplace PolicyApr 8, 2026

A practical guide to drawing enforceable boundaries around workplace AI.

AI at Work treats workplace AI policy as something managers and counsel actually have to write down, not a shiny side topic. It is strongest when it gets specific: data breaches, discrimination claims, IP disputes, and the line between AI a worker can use and AI that should stay…

Alumni @ RopesTalk: Conversation with Steven Obiajulu, UseJuniorSep 22, 2025

A grounded founder story where legal training, technical roots, and product trust all stay in view.

The episode follows Stephen Obijulu from MIT mechanical engineering to Harvard Law School, then through patent work and the Private Capital Transactions Group at Ropes & Gray before he leaves to start UseJunior.

Culture & Compliance Chronicles: Lawyering with Purpose—Human Rights, Culture & Social Responsibility with Archana KotechaSep 17, 2025

A steady compliance conversation that turns supply chain oversight into a practical lesson in responsibility.

This episode keeps its attention on how compliance work looks once it gets near real operations. The pace is calm and measured, and the strongest parts are the practical ones: how supplier access gets handled, what a constructive closing meeting sounds like, and how risk can be…

Podcasts like RopesTalk

  • Take on Board

    Practical wisdom for better boardrooms.

  • Freakonomics RadioFreakonomics Radio + Stitcher

    Stephen Dubner tests bourbon economics, Alzheimer's research, and money advice against hard data.

  • MarketplaceMarketplace

    Daily business news with Kai Ryssdal, tracking Fed policy, oil shocks, and private credit.

  • The Prof G PodVox Media Podcast Network

    Galloway rotates Office Hours Q&A, Raging Moderates politics, and China Decode geopolitics weekly.

  • The Ramsey ShowRamsey Network

    Tough love for messy money decisions.

  • How to MoneyiHeartPodcasts

    Joel and Matt answer listener money questions weekly in the show's Ask HTM segments.

Episodes

  1. 1

    Competition Corner: U.S. Antitrust Law Reaches That? Extraterritoriality Developments

    Oct 8, 2026·18m
  2. 2

    Before You Meet: Hot Topics for 401(k), 403(b), and Other Defined Contribution Retirement Plan Committees in Q4 2026

    Oct 5, 2026·21m
  3. 3

    Culture & Compliance Chronicles: Data, People & Purpose—Navigating the Talent Landscape in Ethics & Compliance with the Leonid Group

    Sep 30, 2026·38m
  4. 4

    Alumni @ RopesTalk: Inside Toast’s Legal Evolution with Brian Elworthy

    Sep 21, 2026·31m
  5. 5

    New SEC Guidance and Impact to CV Fund Election Periods

    Sep 11, 2026·9m
  6. 6

    Culture & Compliance Chronicles: Beyond the Rulebook—The Art of People-First Compliance with Nadège Rochel

    Sep 9, 2026·35m
  7. 7

    Federal Clearance Is Not Always the Finish Line: State AGs and Private Plaintiffs Emerge as Merger Risks

    Jul 23, 2026·13m
  8. 8

    Culture & Compliance Chronicles: Meditation—A Tool for Presence, Clarity, and Performance in an Ever-Changing World with Michael Miller

    Jul 22, 2026·43m
  9. 9

    Culture & Compliance Chronicles: Of Puppets and People—Humanizing Ethics & Compliance with Fraser Simpson

    Jun 17, 2026·30m
  10. 10

    Culture & Compliance Chronicles: Sleep, Science & Success—Unlocking Chronoleadership

    May 20, 2026·38m
  11. 11

    Culture & Compliance Chronicles: Wonder, Creativity and the Power of Play - Inspiring Change in Compliance with Rebecca Mayfield

    This episode explores how fostering wonder, creativity, and play can inspire positive change in compliance and organizational culture, featuring an interview with Rebecca Mayfield, Group Compliance Director at Merlin Entertainment.

    Apr 15, 2026·31m
  12. 12

    AI at Work – Drafting an Effective and Compliant AI Workplace Policy

    Three Ropes & Gray partners — Jan Cormier, Greg Demers (employment practice), and Alyssa Horton (asset management) — walk through the key components of a legally compliant workplace AI policy.

    Apr 8, 2026·21m·1 clip
  13. 13

    Culture & Compliance Chronicles: The Human Factor—Psychology and Cybersecurity in the Digital Age with Sarah Zheng

    Neuropsychologist Sarah Zheng, researcher at UCL's Dawes Centre for Future Crimes and co-author of 'The Psychology of Cyber Security,' joins hosts Nitish Appadhyay, Amanda Raad, and Richard Bistrong to examine why human behaviour remains the primary vulnerability in organisational cybersecurity.

    Mar 18, 2026·34m·2 clips
  14. 14

    Okaying a Premium Problem: When Voluntary Benefits Become Involuntary Lawsuits

    This podcast discusses the emergence of class action lawsuits targeting voluntary benefit plans under ERISA, featuring insights from legal and benefits consulting experts on litigation risks and fiduciary responsibilities.

    Mar 9, 2026·15m
  15. 15

    Non-Financial Misconduct Miniseries: Episode 4 – The Impact of Toxic Culture on Hiring and Retention

    This episode explores how toxic organizational culture impacts hiring and retention, featuring expert guests discussing corporate governance and talent management in the context of non-financial misconduct.

    Feb 23, 2026·33m
  16. 16

    Inside the House—Managing Risk to Drive Commercial Success (Part II)

    This episode explores how legal and compliance professionals should approach AI governance by focusing on decision ownership and governance models rather than technical details, to maintain trusted advisor status in business.

    Feb 19, 2026·17m
  17. 17

    Culture & Compliance Chronicles: Breaking Down Silos—Integrated Assurance in Compliance and Risk with Klaus Moosmayer

    This episode features an interview with Klaus Moosmayer, a former chief compliance officer and current supervisory board member, discussing integrated approaches to compliance, risk, and ethics in organizations.

    Feb 18, 2026·33m
  18. 18

    Inside the House—Managing Risk to Drive Commercial Success (Part I)

    Two senior in-house counsel discuss their experiences partnering with business to achieve growth and manage risk, focusing on private capital transactions and securities regulation.

    Feb 5, 2026·23m
  19. 19

    Five Things Developers Should Remember about New State AI Laws in Health Care

    A legal podcast analyzing state-level AI regulations affecting healthcare technology developers, introducing a new resource called the Health AI Atlas.

    Feb 4, 2026·11m
  20. 20

    The Data Day: World Data Protection Day & Regulatory Insights for 2026

    A legal podcast discussing upcoming UK and EU data, AI, and digital rules in light of rising cybersecurity threats.

    Jan 28, 2026·18m
  21. 21

    Culture & Compliance Chronicles: Networking That Works with Dorie Clark—From Transactional to Transformational

    A discussion on corporate culture and compliance featuring executive education expert Dory Clark.

    Jan 22, 2026·37m
  22. 22

    The Rise of Data Center Funds: Market Drivers and Unique Challenges

    A legal podcast analyzing considerations for private funds investing in data centers, including market trends and structural options.

    Jan 20, 2026·11m
  23. 23

    Considerations for Fund Managers and Investors in Light of EMG Litigation

    Ropes & Gray attorneys analyze a single asset continuation vehicle transaction by Energy and Minerals Group, discussing conflicts of interest and LP consent requirements.

    Jan 15, 2026·17m
  24. 24

    Non-Financial Misconduct Miniseries: Episode 3 – Assessing Culture

    Jan 7, 2026·25m
  25. 25

    Culture & Compliance Chronicles: From Formula 1 to Resilient Leadership – Health, Identity & Success with Annastiina Hintsa

    This episode features an interview with Annastiina Hintsa discussing the connections between well-being, performance, resilient leadership, and organizational culture, drawing from her experiences in Formula 1 and entrepreneurship.

    Dec 17, 2025·37m
  26. 26

    Embracing AI: Driving Legal Innovation

    Dec 17, 2025·11m
  27. 27

    Non-Financial Misconduct Miniseries: Episode 2 – Employment Law Implications of the FCA’s New Rules

    Legal experts discuss the FCA's new rules on non-financial misconduct and their intersection with employment law.

    Dec 10, 2025·31m
  28. 28

    AI at Work – Smarter, Not Riskier: Employer Strategies for Responsible AI Use

    Dec 3, 2025·16m
  29. 29

    Decoding SFDR 2.0: Navigating the European Commission’s Proposed ESG Reforms

    Nov 26, 2025·18m
  30. 30

    Culture & Compliance Chronicles: Inside the Wirecard Scandal—Whistleblowing, Retaliation & Reform with Pav Gill

    Hidden gem

    A financial scandal opens onto a hard workplace question.

    Nov 12, 2025·33m·2 clips
  31. 31

    Practical Considerations for Retirement Plan Sponsors Evaluating Alternative Assets in 401(k)s

    Ropes & Gray attorneys discuss the impact of President Trump's executive order on expanding access to alternative assets in defined contribution retirement plans.

    Oct 30, 2025·20m
  32. 32

    Non-Financial Misconduct Miniseries: Episode 1 – Navigating the FCA's Regulatory Framework

    Ropes & Gray attorneys discuss the FCA's new rules on non-financial misconduct and the regulatory risks for organizations.

    Oct 28, 2025·34m
  33. 33

    Fully Invested: Key Features and Developments in ‘34 Act Funds

    Oct 27, 2025·16m
  34. 34

    Culture & Compliance Chronicles: Boardroom Agility—Strategies for Modern Boards Managing Crises, Compliance & Collective Responsibility

    A discussion on corporate compliance culture with expert Rachel Samarin, covering stakeholder engagement, crisis management, and responsible business.

    Oct 15, 2025·30m
  35. 35

    Navigating Health Plan M&A: Strategies for Success in the Medicare Advantage Market

    A legal podcast analyzing mergers and acquisitions in the Medicare Advantage health plan market.

    Oct 15, 2025·22m
  36. 36

    Fully Invested: The Rise of CITs – Why They’re a Compelling Path for Asset Managers Entering the 401(k) Plan and Retail Markets

    Oct 14, 2025·14m
  37. 37

    Non-binding Guidance: The Administration’s Focus on Direct-to-Consumer Prescription Drug Advertising

    Oct 6, 2025·29m
  38. 38

    Alumni @ RopesTalk: Conversation with Steven Obiajulu, UseJunior

    Stephen starts with engineering, then follows the host through MIT, Harvard Law, Ropes and Gray patent and private capital work, and finally UseJunior.

    Sep 22, 2025·26m·2 clips
  39. 39

    Culture & Compliance Chronicles: Lawyering with Purpose—Human Rights, Culture & Social Responsibility with Archana Kotecha

    Culture comes first.

    Sep 17, 2025·31m·2 clips
  40. 40

    Expanding Access to Alternative Investments in ERISA Plans—Litigation Risks and Practical Considerations

    Sep 10, 2025·13m
  41. 41

    From Chaos to Clarity: Real-World Lessons in Navigating Corporate Crises

    Ropes & Gray attorneys discuss crisis management strategies, focusing on human behavior and culture during high-stakes situations.

    Sep 4, 2025·24m
  42. 42

    Multidimensional Data Reversion: From Search Terms to GenAI—How We Got Here and What We Learned Along The Way

    Hosts discuss the use of AI and data analysis in legal investigations, including applications in accounting fraud and corporate compliance.

    Aug 27, 2025·24m
  43. 43

    Restoring Integrity: Leadership Strategies in Times of Crisis

    A Ropes & Gray attorney and former U.S.

    Aug 21, 2025·23m
  44. 44

    Mentorship, Growth & Opportunity: Experiences from the 2025 Summer Associate Program

    Aug 13, 2025·14m
  45. 45

    Culture & Compliance Chronicles: Beyond Bad Apples—How Context Shapes Corporate Misconduct with Professor Guido Palazzo

    This episode features Professor Guido Palazzo discussing his book 'The Dark Pattern' and exploring how organizational context and culture shape corporate misconduct beyond individual 'bad apples'.

    Aug 13, 2025·32m
  46. 46

    Talkin' Trade: Unpacking Recent ITC Trade Secret Misappropriation Case Law

    Aug 7, 2025·23m
  47. 47

    Navigating Non-Competes and Other Exclusivity Provisions in Collaboration & License Agreements and Other Strategic Transactions in Light of EU Competition Laws

    Aug 4, 2025·16m
  48. 48

    Patient Assistance Programs: Enforcement Trends and Regulatory Challenges

    Legal experts discuss patient assistance programs, their compliance risks, and recent enforcement actions in healthcare.

    Jul 28, 2025·28m
  49. 49

    Culture & Compliance Chronicles: Stories, Strategies & Lessons Learned from Season One

    This episode discusses the importance of culture in compliance and regulatory challenges, featuring insights from experts on leveraging culture as an advantage.

    Jul 16, 2025·27m
  50. 50

    Multidimensional Data Reversion: Implementing AI—Balancing Risks and Opportunities

    RopesTalk attorneys discuss the challenges and risks of implementing generative AI in global corporate environments, focusing on legal and strategic advice.

    Jul 10, 2025·27m
  51. 51

    Medicare Advantage: Enforcement Activity & Broker Arrangements

    Jun 26, 2025·18m
  52. 52

    R&G Dugout: The House v. NCAA Settlement—Tax Implications for Colleges and Universities

    Jun 24, 2025·14m
  53. 53

    Alumni @ RopesTalk: Conversation with Dan Krockmalnic, Boston Globe Media

    Jun 23, 2025·12m
  54. 54

    Culture & Compliance Chronicles: Humanizing Compliance—Creative Approaches with Nicole Rose

    This episode features an interview with Nicole Rose discussing creative and artistic approaches to humanizing compliance in organizational settings.

    Jun 11, 2025·32m
  55. 55

    Culture & Compliance Chronicles: Humanizing Compliance—Creative Approaches with Nicole Rose

    Jun 11, 2025·32m
  56. 56

    Fully Invested: Exchange Act Registered Private Funds (’34 Act)

    Jun 9, 2025·14m
  57. 57

    Multidimensional Data Reversion: Free Text Isn't Free

    Hosts discuss the intersection of data analysis and law, focusing on visualization as a key part of analysis and communication.

    May 28, 2025·25m
  58. 58

    Navigating the SEC's New Marketing Rule FAQ Guidance

    May 27, 2025·12m
  59. 59

    Culture & Compliance Chronicles: Emotionally Charged Leadership with Dina Denham Smith

    This episode features an interview with executive coach Dina Denham-Smith about her book 'Emotionally Charged' and explores leadership strategies for navigating modern workplace challenges.

    May 14, 2025·36m
  60. 60

    Non-binding Guidance: Trends in False Advertising and Related Competitor Disputes Involving FDA-Regulated Products

    May 8, 2025·17m
  61. 61

    R&G Tech Studio: AI Innovation vs. Safety—Insights on a New Executive Order

    May 7, 2025·14m
  62. 62

    Multidimensional Data Reversion: Harnessing Analytics and Visualization

    Apr 30, 2025·26m
  63. 63

    R&G Tech Studio: Navigating AI Literacy—Understanding the EU AI Act

    Apr 29, 2025·13m
  64. 64

    Getting Your Head Around the UK’s New (and Globally Relevant) “Failure to Prevent Fraud” Offence

    Apr 22, 2025·26m
  65. 65

    Real World; Real Problems—First Steps in Addressing Real Estate Partnership Disputes

    Apr 17, 2025·16m
  66. 66

    Culture & Compliance Chronicles: The Power of Business Compliance Ambassadors with Alexandra Belmonte

    Apr 16, 2025·26m
  67. 67

    R&G Dugout: Navigating NIL—The Future of College Athletics and Investments

    Apr 1, 2025·26m
  68. 68

    Multidimensional Data Reversion: E-Discovery Evolution—From Paper Trails to AI

    Mar 26, 2025·19m
  69. 69

    Navigating Whistleblower Trends and Risk Mitigation Under a New Administration

    Mar 25, 2025·15m
  70. 70

    Women @ RopesTalk: Conversation with Jan Sbarbaro, Lyric

    Mar 19, 2025·17m
  71. 71

    Culture & Compliance Chronicles: Organizational Growth Through Fostering Speaking Out and Listening Up with Megan Reitz

    Mar 12, 2025·33m
  72. 72

    Talkin' Trade: Section 337 Domestic Industry Shake-Up—Exploring the Lashify Decision

    Mar 11, 2025·13m
  73. 73

    Alumni @ RopesTalk: DeepSeek Deep Dive with Dr. Vasanth Sarathy, Tufts University

    Feb 26, 2025·26m
  74. 74

    Women @ RopesTalk: Conversation with Katy Motiey, Extreme Networks

    Feb 19, 2025·28m
  75. 75

    Antitrust Insights: New HSR Rules Now in Effect

    Feb 13, 2025·16m
  76. 76

    Culture & Compliance Chronicles: How Cultural Understanding Empowers Compliance with Tal Freilich

    Feb 12, 2025·37m
  77. 77

    Controlling Opinions: The Outlook for Controlled Substances in 2025

    Feb 11, 2025·31m
  78. 78

    R&G Dugout: Show Me the Money—Fund Formation & Management

    Jan 22, 2025·17m
  79. 79

    Culture & Compliance Chronicles: Bridging and Cultures—Contextualizing Global Compliance with Letitia Adu-Ampoma

    Jan 15, 2025·31m
  80. 80

    Antitrust Insights: New HSR Rules—Impacts to the Pharma Industry

    Dec 16, 2024·18m
  81. 81

    Welcome to the R&G Dugout: Sports Investing—It's a Whole New Ballgame

    Dec 12, 2024·15m
  82. 82

    Culture & Compliance Chronicles: Building a Culture of Fairness and Transparency with Danny Mayhew of Sanofi

    Dec 11, 2024·33m
  83. 83

    A Word for Our Sponsors: GP-Led Secondary Perceptions Report with Campbell Lutyens

    Dec 10, 2024·21m
  84. 84

    Health Care Transaction Laws Unwrapped: Recent Antitrust Developments

    Dec 3, 2024·16m
  85. 85

    Non-binding Guidance: Clinical Trial Diversity in Focus

    Nov 19, 2024·15m
  86. 86

    Controlling Opinions: Navigating DEA Diversion Investigations

    Nov 18, 2024·21m
  87. 87

    Culture & Compliance Chronicles: Innovative Compliance Strategies with Katie Daniels

    Nov 14, 2024·38m
  88. 88

    Women @ RopesTalk: Conversation with Veronica Lei, Eli Lilly

    Nov 13, 2024·21m
  89. 89

    Health Care Transaction Laws Unwrapped: Deal Impacts for Private Equity Firms, MSOs & DSOs

    Nov 12, 2024·19m
  90. 90

    California Law for Asset Managers: Navigating Noncompete Statutes & Workplace Violence Prevention Plans

    Oct 31, 2024·15m
  91. 91

    Health Care Transaction Laws Unwrapped: Recent Developments on the West Coast

    Oct 29, 2024·17m
  92. 92

    Non-binding Guidance: The Demise of Chevron and Implications for Future APA Challenges

    Oct 22, 2024·37m
  93. 93

    Culture & Compliance Chronicles: Navigating Ethical Dilemmas and Building Trust with Dr. Brennan Jacoby

    Oct 17, 2024·36m
  94. 94

    R&G Tech Studio Presents: Venture Capital and Emerging Companies Partner Raj Banerjee

    Oct 16, 2024·11m
  95. 95

    Health Care Transaction Laws Unwrapped: Recent Developments on the East Coast

    Oct 15, 2024·26m
  96. 96

    Talkin' Trade: Navigating the Post-Loper Bright World at the ITC

    Oct 8, 2024·14m
  97. 97

    Culture & Compliance Chronicles Special: "Live" Edition: Voices from Across the Compliance Community on Culture

    Oct 3, 2024·23m
  98. 98

    Health Care Transaction Laws Unwrapped: Recent Developments in the Midwest

    Oct 1, 2024·18m
  99. 99

    Women @ RopesTalk: Conversation with Laura Berner, TRex Bio

    Sep 18, 2024·18m
  100. 100

    Alumni @ RopesTalk: Board Service Insights with Alums Jennifer Borggaard & Robert Shapiro

    Sep 17, 2024·27m
  101. 101

    Health Care Transaction Laws Unwrapped: Navigating Expanding Government Oversight of Health Care Investments

    Sep 17, 2024·19m
  102. 102

    R&G Tech Studio Presents: IP Litigation Counsel Rachael Bacha

    Sep 16, 2024·16m
  103. 103

    Culture & Compliance Chronicles: How Corporate Culture Drives Investment and Performance Outcomes

    Sep 10, 2024·34m
  104. 104

    Interval and Tender Offer Funds for Private Fund Managers

    Aug 29, 2024·13m
  105. 105

    A Word for Our Sponsors: GP-Led Secondaries Outlook with Devon Park Advisors (Part II)

    Aug 28, 2024·22m
  106. 106

    A Word for Our Sponsors: GP-Led Secondaries Outlook with Devon Park Advisors (Part I)

    Aug 15, 2024·16m
  107. 107

    R&G Tech Studio Presents: IP Litigation Counsel Matthew Shapiro

    Aug 14, 2024·21m
  108. 108

    Culture & Compliance Chronicles: The FEPA Factor—Will the DOJ's Latest Tool Reshape the Landscape of Anti-Corruption Enforcement and Compliance?

    Aug 13, 2024·32m
  109. 109

    Women @ RopesTalk: Conversation with Neena Reddy, Blue Owl Capital

    Aug 7, 2024·16m
  110. 110

    Non-binding Guidance: How Drug and Device Companies Can Tackle Internet Misinformation

    Aug 1, 2024·18m
  111. 111

    Controlling Opinions: Latest Developments Regarding Controlled Substance Issues in Telemedicine

    Jul 29, 2024·22m
  112. 112

    Decoding Digital Health: Artificial Intelligence Unveiled—The Science Behind AI

    Jul 25, 2024·25m
  113. 113

    California Privacy Laws for Asset Managers

    Jul 23, 2024·19m
  114. 114

    Culture & Compliance Chronicles: A Journey into Team Ethical Culture with Guillem Casoliva Cabana

    Jul 16, 2024·32m
  115. 115

    SCOTUS and the Future of the Administrative State: After Jarkesy and Loper Bright

    Jul 12, 2024·27m
  116. 116

    Decoding Digital Health: Conversation with Dr. Bernardo Bizzo, Mass General Brigham AI

    Jul 11, 2024·16m
  117. 117

    The Data Day: Recent Developments in AI Governance and State Privacy Laws

    Jul 10, 2024·14m
  118. 118

    Non-binding Guidance: FDA Regulatory & Enforcement Risks Relevant to Academic Medical Centers, Health Systems and Research Institutions

    Jun 28, 2024·22m
  119. 119

    A New Wave of ERISA Class Actions?: Some Employer/Fiduciary Implications of Lewandowski v. Johnson & Johnson

    Jun 25, 2024·19m
  120. 120

    Alumni @ RopesTalk: Conversation with Charles Soule, Comic Book Writer & Novelist

    Jun 24, 2024·24m
  121. 121

    Hospital and Health System Value-Based Care Strategy Update: Lightning Round with Practitioners in the Trenches

    Jun 20, 2024·20m
  122. 122

    Asset Management Transatlantic Regulatory Roundup: Differences in SEC and FCA Regulation of Fund Advisers

    Jun 17, 2024·18m
  123. 123

    Culture & Compliance Chronicles: Navigating Corporate Culture and Risk

    Jun 10, 2024·32m
  124. 124

    SCOTUS and the Future of the Administrative State

    Jun 6, 2024·31m
  125. 125

    False Claims Act Trends: Q&A with Former DOJ Civil Frauds Attorney and Ropes & Gray Partner Amy Kossak

    May 30, 2024·20m
  126. 126

    Women @ RopesTalk: Conversation with Svetlana Lucas, Scribe Therapeutics

    May 22, 2024·23m
  127. 127

    Decoding Digital Health: AI/ML Webinar Recap—U.S. FDA & European Perspectives

    May 21, 2024·19m
  128. 128

    R&G Tech Studio Presents: Managing Principal and Global Head of Advanced E-Discovery and A.I. Strategy Shannon Capone Kirk

    May 16, 2024·22m
  129. 129

    Revisiting Pooled Employer Plans (“PEPs”): A Cost-Effective, Low-Risk Solution for Providing Retirement Plan Coverage (Part II)

    May 13, 2024·22m
  130. 130

    Hazards On—PFAS is Now a Federal Concern

    May 9, 2024·29m
  131. 131

    Insurance Brokerage M&A: Key Considerations

    Apr 29, 2024·19m
  132. 132

    Women @ RopesTalk: Conversation with Jill Varner, Versus Capital Advisors

    Apr 24, 2024·20m
  133. 133

    There Has to Be a Better Way?: Curiosity & Empathy: A Better Way to Approach Data?

    Apr 19, 2024·38m
  134. 134

    There Has to Be a Better Way?: Data-Powered Insights: Telling Your Risk, Culture, and Ethics Stories with Data

    Apr 3, 2024·39m
  135. 135

    2024 U.S. Health Care Fraud, Waste & Abuse Trends (Part III): Enforcement Actions

    Apr 2, 2024·28m
  136. 136

    California Law for Asset Managers: California ESG Landscape

    Apr 1, 2024·19m
  137. 137

    Women @ RopesTalk: Conversation with Morgan (Dean) O'Neill, Sound Point Capital Management

    Mar 27, 2024·16m
  138. 138

    Alumni @ RopesTalk: Conversation with Eric Yecies, LifeMD

    Mar 26, 2024·13m
  139. 139

    2024 U.S. Health Care Fraud, Waste & Abuse Trends (Part II): Guidance on Clinical Laboratory Arrangements

    Mar 26, 2024·15m
  140. 140

    There Has to Be a Better Way?: Faith@Work: A Personal Conversation on Ethics and Compliance

    Mar 20, 2024·42m
  141. 141

    2024 U.S. Health Care Fraud, Waste & Abuse Trends (Part I): Advisory Opinions on Patient Inducements

    Mar 19, 2024·17m
  142. 142

    A Word for Our Sponsors: Contours of a Good Compensation Plan

    Mar 8, 2024·31m
  143. 143

    Controlling Opinions: Current Developments in Cannabis Research

    Mar 7, 2024·24m
  144. 144

    There Has to Be a Better Way?: Transforming Compliance Education

    Mar 6, 2024·40m
  145. 145

    Non-binding Guidance: Preview of the Second Annual Ropes & Gray Rare Disease Forum

    Feb 29, 2024·9m
  146. 146

    Women @ RopesTalk: Conversation with Jenny Walsh, Sixth Street

    Feb 22, 2024·24m
  147. 147

    There Has to Be a Better Way?: Understanding the World of Environmental Crimes

    Feb 21, 2024·36m
  148. 148

    There Has to Be a Better Way?: Reimagining Compliance Training

    Feb 7, 2024·43m
  149. 149

    Fully Invested: What to Know About Private Equity Operating Companies

    Feb 6, 2024·14m
  150. 150

    Asset Management Transatlantic Regulatory Roundup: Rules, Culture, Valuations & ESG

    Feb 6, 2024·26m
  151. 151

    Non-binding Guidance: U.S. Life Sciences Regulatory and Compliance Outlook 2024 (Part IV): Digital Health

    Jan 31, 2024·29m
  152. 152

    Insights from OIG’s Strategic Plan for Oversight of Managed Care (Part II)

    Jan 30, 2024·11m
  153. 153

    R&G Tech Studio Presents: Ed Black as Technology Strategy Leader

    Jan 30, 2024·26m
  154. 154

    The Data Day: Protecting Your Company and Your Data in the Wake of a Cyber Incident

    Jan 26, 2024·20m
  155. 155

    Non-binding Guidance: U.S. Life Sciences Regulatory and Compliance Outlook 2024 (Part III): Advertising and Promotion

    Jan 25, 2024·31m
  156. 156

    Talkin’ Trade: Third-Party Subpoenas in ITC Section 337 Proceedings

    Jan 24, 2024·20m
  157. 157

    There Has to Be a Better Way?: What’s Wrong With Doing the Right Thing?

    Jan 24, 2024·39m
  158. 158

    Revisiting Pooled Employer Plans (“PEPs”): A Cost-Effective, Low-Risk Solution for Providing Retirement Plan Coverage (Part I)

    Jan 22, 2024·23m
  159. 159

    Non-binding Guidance: U.S. Life Sciences Outlook 2024 (Part II): Product Development and Pricing

    Jan 22, 2024·33m
  160. 160

    Non-binding Guidance: U.S. Life Sciences Regulatory and Compliance Outlook 2024 (Part I): FDA Enforcement and Litigation

    Jan 17, 2024·28m
  161. 161

    Insights from OIG’s Strategic Plan for Oversight of Managed Care (Part I)

    Jan 16, 2024·10m
  162. 162

    A Word for Our Sponsors: A Conversation with Vikrant Raina of BV Investment Partners

    Jan 11, 2024·25m
  163. 163

    There Has to Be a Better Way?: 2024 Outlook: What the New Year Brings for Business, Ethics, and Compliance

    Jan 10, 2024·34m
  164. 164

    New California Climate Disclosure Requirements and Their Relevance to Asset Managers and their Portfolio Companies

    Dec 19, 2023·15m
  165. 165

    Women @ RopesTalk: Conversation with Marjorie Goux, Rodan & Fields

    Dec 14, 2023·32m
  166. 166

    There Has to Be a Better Way?: A Year of “Better Ways?”

    Dec 13, 2023·41m
  167. 167

    Alumni @ RopesTalk: Conversation with George Kopcsay, Atlas Air

    Dec 12, 2023·17m
  168. 168

    Overview of New California Law Requiring Disclosure on Diversity in VC Investments by “Venture Capital Companies”

    Dec 5, 2023·18m
  169. 169

    Rated Note Fund Structures: The Impact of the NAIC’s SSAP 26

    Nov 30, 2023·12m
  170. 170

    There Has to Be a Better Way?: What is the “Right Thing” to Do?

    Nov 29, 2023·38m
  171. 171

    Controlling Opinions: Introducing Ropes & Gray’s Controlled Substances Compliance Update

    Nov 20, 2023·18m
  172. 172

    Recent Trends & Developments in Health Care Joint Ventures: Different Joint Venture Models

    Nov 16, 2023·24m
  173. 173

    The Data Day: Data Protection Laws in India—A Conversation with Sajai Singh of J. Sagar Associates

    Nov 16, 2023·26m
  174. 174

    Non-binding Guidance: FDA’s Draft Guidance on Communication of Scientific Information on Unapproved Uses of Medical Products

    Nov 14, 2023·24m
  175. 175

    There Has to Be a Better Way?: Compliance Stories: Lessons Learned in the Field

    Nov 8, 2023·38m
  176. 176

    R&G Tech Studio Presents: Litigation & Enforcement Partner Helen Gugel

    Nov 7, 2023·14m
  177. 177

    Recent Trends & Developments in Health Care Joint Ventures: Payor/Provider and Provider/Provider Joint Ventures

    Nov 2, 2023·20m
  178. 178

    Non-binding Guidance: FDA’s Proposed Rule on Laboratory Developed Tests

    Oct 30, 2023·24m
  179. 179

    There Has to Be a Better Way?: An Outsider with an Inside View: Researcher Daniel Beunza “Taking the Floor” on Wall Street

    Oct 25, 2023·38m
  180. 180

    Recent Trends & Developments in Health Care Joint Ventures: Nonprofit/For-Profit Joint Ventures

    Oct 19, 2023·15m
  181. 181

    A Word for Our Sponsors: Philanthropy & Giving Strategies by Fund Sponsors

    Oct 18, 2023·11m
  182. 182

    There Has to Be a Better Way?: Not All AI is Generative: AI Strategist and Best-Selling Author Shannon Kirk on the Power of Metrics and Words

    Oct 11, 2023·32m
  183. 183

    Evolution in Real Estate Joint Ventures

    Oct 10, 2023·12m
  184. 184

    Recent Trends & Developments in Health Care Joint Ventures: Five Key Considerations for a Successful Joint Venture

    Oct 5, 2023·17m
  185. 185

    There Has to Be a Better Way?: Playing in the Sandbox with Bots: Nitish Upadhyaya Discusses the Role of the Human in an Increasingly Artificial World

    Sep 27, 2023·40m
  186. 186

    A Word for Our Sponsors: A Conversation with Kase Jubboori of Bain Capital

    Sep 26, 2023·28m
  187. 187

    R&G Tech Studio Presents: Data, Privacy & Cybersecurity Co-Leader Rohan Massey

    Sep 25, 2023·16m
  188. 188

    Recent Trends & Developments in Health Care Joint Ventures

    Sep 21, 2023·14m
  189. 189

    Women @ RopesTalk: Conversation with Kelly Gold, CAMP4 Therapeutics

    Sep 19, 2023·24m
  190. 190

    There Has to Be a Better Way?: Is Transparency in Business the Key to Halting Human Trafficking? A Conversation with Actor and Activist Julia Ormond

    Sep 13, 2023·34m
  191. 191

    Commercial Real Estate Joint Ventures and Funds: What’s the Difference?

    Sep 12, 2023·18m
  192. 192

    The Inevitable Rise of NAV Financing

    Sep 8, 2023·22m
  193. 193

    Activism for Non-Activists

    Sep 7, 2023·16m
  194. 194

    Carbon Talk: An Introduction to the Global Carbon Markets

    Sep 6, 2023·10m
  195. 195

    California Law for Asset Managers: California Fee Disclosure Law

    Aug 24, 2023·17m
  196. 196

    R&G Tech Studio Presents: Mergers & Acquisitions Partner Sarah Young

    Aug 24, 2023·14m
  197. 197

    There Has to Be a Better Way?: Company Leaders First: Former Coach Kevin Espinoza on How to Better Integrate Compliance Within Businesses

    Aug 23, 2023·36m
  198. 198

    The Sponsor’s Edge: Insights on Growth and Venture Investing—Alternatives to Down Rounds and Bridging Valuation Gaps (Part II)

    Aug 17, 2023·10m
  199. 199

    Talkin' Trade: Early Off-Ramps from ITC Section 337 Investigations?

    Aug 17, 2023·18m
  200. 200

    California Law for Asset Managers: An Overview of Lobbying Laws Applicable to Soliciting California Pension Plans and Retirement Systems

    Aug 10, 2023·13m
  201. 201

    There Has to Be a Better Way?: What Pop Culture Gets Wrong: Leading AI Ethicist Rumman Chowdhury Defines the Real Risks of Artificial Intelligence

    Aug 9, 2023·42m
  202. 202

    The Sponsor's Edge: Insights on Growth and Venture Investing ”Alternatives to Down Rounds and Bridging Valuation Gaps (Part I)

    Aug 7, 2023·11m
  203. 203

    Practical Considerations for At-Home Care Post-PHE

    Jul 27, 2023·20m
  204. 204

    There Has to Be a Better Way?: Do Consumers Care About Corporate Compliance? New Research Says Yes

    Jul 26, 2023·43m
  205. 205

    Women @ RopesTalk: Conversation with Jennifer Zachary, Merck

    Jul 25, 2023·30m
  206. 206

    Using the COSO Internal Control Framework for Sustainability Reporting

    Jul 20, 2023·55m
  207. 207

    Operational Due Diligence: Considerations for Investors

    Jul 19, 2023·8m
  208. 208

    Non-binding Guidance: Introducing the U.S. Medical Device Recalls Resource Manual

    Jul 17, 2023·8m
  209. 209

    Talkin' Trade: Trade Secrets, False Advertising, Antitrust, Oh My! — Non-Statutory Claims at the ITC

    Jul 17, 2023·20m
  210. 210

    Value-based Care Collides with Competition: Antitrust and Enforcement Considerations

    Jul 13, 2023·18m
  211. 211

    There Has to Be a Better Way?: A Beautiful Association: Antoine Ferrère of Novartis Discusses the Link Between Psychological Safety and Compliance

    Jul 13, 2023·40m
  212. 212

    Value-based Care Collides with Competition: Deal Impacts for MSOs/DSOs

    Jun 29, 2023·16m
  213. 213

    Digital Assets Discussion: Consequences of the Proposed Safeguarding Rule for Crypto Asset Custody

    Jun 28, 2023·16m
  214. 214

    There Has to Be a Better Way?: The Power of Pause: A Retrospective on the Last Six Months

    Jun 28, 2023·28m
  215. 215

    Alumni @ RopesTalk: Conversation with Heidy King-Jones

    Jun 27, 2023·29m
  216. 216

    R&G Tech Studio Presents: IP Transactions & Technology Counsel Emily Karlberg

    Jun 27, 2023·19m
  217. 217

    Women @ RopesTalk: Conversation with Jennifer Chun Barry, Meta

    Jun 21, 2023·43m
  218. 218

    Value-based Care Collides with Competition: Deal Impacts for Private Equity Companies

    Jun 15, 2023·12m
  219. 219

    There Has to Be a Better Way?: Miracle on the Hill: How to Build Consensus and Achieve Results in Divided Organizations

    Jun 14, 2023·42m
  220. 220

    Treacherous Shoals—Navigating Growing Anti-ESG Sentiment: Recent Developments Impacting Asset Managers

    Jun 8, 2023·1h 4m
  221. 221

    Value-based Care Collides with Competition: Recent Developments on the East Coast

    Jun 1, 2023·28m
  222. 222

    There Has to Be a Better Way?: GE’s Global Investigations Chief Counsel Katy Choo Discusses the Art of Investigations

    May 31, 2023·34m
  223. 223

    Why Conduct a GP-Led Secondary?

    May 23, 2023·10m
  224. 224

    The Applicability of the SEC’s Proposed Custody Rule to Real Estate

    May 22, 2023·27m
  225. 225

    R&G Tech Studio Presents: Strategic Transactions Co-Leader Marko Zatylny

    May 18, 2023·20m
  226. 226

    Value-based Care Collides with Competition: Recent Developments on the West Coast

    May 18, 2023·18m
  227. 227

    There Has to Be a Better Way?: Compliance Leader and Ex-Marine Patrick McGowan Digs Into the Predictive Power of Data Analytics

    May 17, 2023·41m
  228. 228

    Non-binding Guidance: Recent Developments in Oncology Drug Development

    May 10, 2023·21m
  229. 229

    Value-based Care Collides with Competition

    May 4, 2023·14m
  230. 230

    There Has to Be a Better Way?: Part II: Award-Winning Author Benjamin van Rooij Offers a Practical Framework for How Organizations and Lawmakers Can Improve Human Conduct

    May 3, 2023·30m
  231. 231

    R&G Tech Studio Presents: Litigation & Enforcement Partner Ama Adams

    May 2, 2023·11m
  232. 232

    Current Topics for Corporates Trading Derivatives

    May 2, 2023·7m
  233. 233

    Women @ RopesTalk: Conversation with Karna Nisewaner, Cadence Design Systems

    Apr 26, 2023·28m
  234. 234

    The Data Day: Tracking Cybercriminals and Nation-State Actors in the World of Cryptocurrency—A Conversation with Jackie Koven of Chainalysis

    Apr 25, 2023·22m
  235. 235

    There Has to Be a Better Way?: Part I: Award-Winning Author Benjamin van Rooij Explains Why Understanding Human Behavior is Essential to Law and Compliance

    Apr 19, 2023·35m
  236. 236

    R&G Tech Studio Presents: Intellectual Property Litigation Partner Andrew Radsch

    Apr 18, 2023·20m
  237. 237

    2023 Real Estate Market Outlook

    Apr 10, 2023·13m
  238. 238

    DOJ’s Withdrawal of Policy Statements Relating to Antitrust Enforcement in Healthcare Markets

    Apr 6, 2023·9m
  239. 239

    There Has to Be a Better Way?: Not All Messaging Apps Are Ephemeral

    Apr 5, 2023·40m
  240. 240

    R&G Tech Studio Presents: IP Transactions and Technology Co-Leader Megan Baca

    Apr 4, 2023·13m
  241. 241

    There Has to Be a Better Way?: Skin in the Game? Dr. Caitlin Handron Discusses How Compliance Incentives Might Work in Practice

    Mar 29, 2023·36m
  242. 242

    Contingent Dislocation Funds: Nimble Structures Built for Market Events

    Mar 23, 2023·12m
  243. 243

    There Has to Be a Better Way?: Assumptions v. Research: Unpacking Recent DOJ Policy Initiatives

    Mar 22, 2023·38m
  244. 244

    R&G Tech Studio Presents: TMT "Dealmaker of the Year" Mike Roh

    Mar 21, 2023·16m
  245. 245

    There Has to Be a Better Way?: Award-Winning Data Journalist David Yanofsky Explains How to Tell Stories from Data and Why Precision Matters

    Mar 15, 2023·30m
  246. 246

    R&G Tech Studio Presents: Intellectual Property Litigation Chair Steve Pepe

    Mar 8, 2023·18m
  247. 247

    Alumni @ RopesTalk: Conversation with Beibei Sun, Sanofi

    Mar 6, 2023·28m
  248. 248

    The Data Day: A Deeper Look Into the California Consumer Privacy Act (CCPA) & California Privacy Rights Act (CPRA)

    Mar 2, 2023·23m
  249. 249

    Women @ RopesTalk: Conversation with Siobhan Pomeroy, Gilead Sciences

    Mar 2, 2023·26m
  250. 250

    U.S. Life Sciences Outlook 2023 (Part IV): Additional Insights on Expected Developments

    Mar 1, 2023·12m
  251. 251

    There Has to Be a Better Way?: Attorney-Turned-Journalist Megan Zwiebel Talks About the Power of Stories and the Art of Persuasion

    Mar 1, 2023·29m
  252. 252

    Rated Note Feeder Structures: 2023 Update

    Feb 27, 2023·10m
  253. 253

    U.S. Life Sciences Outlook 2023 (Part III): Agency Litigation Challenges

    Feb 27, 2023·15m
  254. 254

    U.S. Life Sciences Outlook 2023 (Part II): Anticipated Agency Policy Developments

    Feb 23, 2023·22m
  255. 255

    Private Fund Regulatory Update: Recent Developments Regarding the Marketing Rule FAQ, SEC’s Rulemaking Agenda and 2023 Exam Priorities

    Feb 22, 2023·24m
  256. 256

    U.S. Life Sciences Regulatory Outlook 2023 (Part I): 2022 Trends Expected to Continue Into 2023

    Feb 21, 2023·13m
  257. 257

    There Has to Be a Better Way?: Dr. Caitlin Handron, Senior Consultant and Behavioral Scientist at R&G Insights Lab, Discusses the Role of Cultural Psychology in Solving Complex Organizational Challenges

    Feb 15, 2023·36m
  258. 258

    Talkin' Trade: How to “Fix” Section 337 and the ITC

    Feb 7, 2023·25m
  259. 259

    There Has to Be a Better Way?: Hui Chen, R&G Insights Lab Senior Advisor, Describes Her Atypical Career Path and How It Enriches Her Compliance Insights

    Feb 1, 2023·31m
  260. 260

    Driving a Successful GP-LP Relationship

    Jan 31, 2023·10m
  261. 261

    The Data Day: World Data Protection Day and 2023 Trends & Hot Topics

    Jan 30, 2023·16m
  262. 262

    There Has to Be a Better Way?: Zach Coseglia, Inspiration Junkie and R&G Insights Lab Founder, Describes the Journey to Combine a Data-Driven and Human-Centered Approach to Solving Problems

    Jan 18, 2023·34m
  263. 263

    Decoding Digital Health: Trans-Atlantic Transfers of Health Data

    Jan 12, 2023·21m
  264. 264

    R&G Tech Studio Presents: Energy & Infrastructure Co-Leader Taylor Hart

    Dec 29, 2022·16m
  265. 265

    R&G Tech Studio Presents: IP Transactions and Technology Associate Josh Jackson

    Dec 28, 2022·17m
  266. 266

    R&G Tech Studio Presents: Asset Management Counsel Ed Baer

    Dec 23, 2022·19m
  267. 267

    Having Decided to Rebalance a PE Portfolio—Now What? Considerations for LPs Contemplating a Secondary Sale

    Dec 20, 2022·11m
  268. 268

    R&G Tech Studio Presents: Data, Privacy & Cybersecurity Partner Fran Faircloth

    Dec 19, 2022·20m
  269. 269

    Antitrust and Health Care Enforcers Announce Collaboration

    Dec 19, 2022·9m
  270. 270

    The DOL’s Latest Guidance on ESG Investing and Proxy Voting—Key Implications for Plan Fiduciaries

    Dec 16, 2022·27m
  271. 271

    R&G Tech Studio Presents: Data, Privacy & Cybersecurity Co-Leader Ed McNicholas

    Dec 13, 2022·15m
  272. 272

    Non-binding Guidance: The Regulatory Landscape for Drug Compounding—10 Years After the NECC Outbreak

    Dec 5, 2022·13m
  273. 273

    Can Agencies Do That? Limits to Executive Action Regarding Drug Pricing

    Dec 1, 2022·29m
  274. 274

    R&G Tech Studio Presents: IP Transactions and Technology Partner Regina Sam Penti

    Nov 30, 2022·14m
  275. 275

    Talkin’ Trade: Examining the Interplay Between the ITC and District Courts

    Nov 29, 2022·21m
  276. 276

    Non-binding Guidance: Key Takeaways from FDA’s Final Guidance on Clinical Decision Support Software

    Nov 21, 2022·20m
  277. 277

    Women @ RopesTalk: Conversation with Lisa Mango, One Medical

    Nov 17, 2022·31m
  278. 278

    FinCEN’s Beneficial Ownership Reporting Requirements: Key Takeaways and Open Questions

    Nov 16, 2022·12m
  279. 279

    Medicare Rules: Promoting Competition?

    Nov 15, 2022·18m
  280. 280

    R&G Tech Studio Presents: Venture Capital & Emerging Companies Co-Leader Brad Flint

    Nov 15, 2022·17m
  281. 281

    Digital Assets Discussion: Implications of Ooki DAO CFTC Enforcement Action

    Nov 14, 2022·13m
  282. 282

    Decoding Digital Health: Digital Health Dealmaking with John Vaughan, Verily Life Sciences (Part II)

    Nov 9, 2022·16m
  283. 283

    R&G Tech Studio Presents: Private Equity Partner Scott Abramowitz

    Nov 2, 2022·10m
  284. 284

    Decoding Digital Health: Digital Health Dealmaking with John Vaughan, Verily Life Sciences (Part I)

    Oct 26, 2022·17m
  285. 285

    Credit Facilities for Registered Investment Funds

    Oct 20, 2022·12m
  286. 286

    Women @ RopesTalk: Conversation with Christina Carlson, HI-Bio

    Oct 19, 2022·27m
  287. 287

    Recent Legal Trends in Restrictive Covenant Enforcement and What Employers Should Know

    Oct 18, 2022·16m
  288. 288

    Non-binding Guidance: Continued Global Pressure on Drug Pricing & Reimbursement and the Next Frontiers for Effective Market Access

    Oct 13, 2022·22m
  289. 289

    Latinx|Hispanic Heritage Month: Conversation with Anilu Vazquez-Ubarri, TPG

    Oct 12, 2022·27m
  290. 290

    ESG and the State Coffers: An Emerging Political Battleground

    Oct 11, 2022·25m
  291. 291

    Latinx|Hispanic Heritage Month: Conversation with Jorge Lopez, Jr., Memorial Sloan Kettering Cancer Center (MSK)

    Oct 5, 2022·24m
  292. 292

    Latinx|Hispanic Heritage Month: Conversation with Lola Velazquez-Aguilu, Medtronic

    Sep 15, 2022·28m
  293. 293

    Fully Invested: SEC Requests

    Sep 13, 2022·15m
  294. 294

    Talkin' Trade: All About Ancillary Proceedings

    Sep 6, 2022·20m
  295. 295

    Alumni @ RopesTalk: Conversation with Erin Abood, Stanford University

    Aug 30, 2022·19m
  296. 296

    Fully Invested: Private Credit Funds

    Aug 9, 2022·11m
  297. 297

    Fully Invested: Fund of Funds

    Jul 26, 2022·11m
  298. 298

    Women @ RopesTalk: Conversation with Mallory Capasso, Luxury Brand Partners

    Jul 20, 2022·28m
  299. 299

    Fully Invested: Derivatives Trading Agreements

    Jul 12, 2022·10m
  300. 300

    Digital Assets Discussion: Crypto Special Situations and Dislocation Funds

    Jul 8, 2022·7m
  301. 301

    Recent ETF Developments: Cryptocurrency ETFs and ETPs

    Jul 7, 2022·11m
  302. 302

    Fully Invested: Form ADV

    Jun 28, 2022·17m
  303. 303

    ERISA 401(k)/403(b) Fiduciary Developments: The Grab Bag Episode

    Jun 23, 2022·28m
  304. 304

    Women @ RopesTalk: Conversation with Katerina Novak, Viking Global Investors

    Jun 22, 2022·28m
  305. 305

    Digital Assets Discussion: Stablecoins

    Jun 22, 2022·11m
  306. 306

    Fully Invested: Retailization of Private Fund Products

    Jun 17, 2022·20m
  307. 307

    Recent ETF Developments: Wrappers, Conversions and Exams

    Jun 16, 2022·13m
  308. 308

    Pre-Approval of Liquidity Opportunities

    Jun 13, 2022·9m
  309. 309

    Fully Invested: Co-Investments

    Jun 8, 2022·11m
  310. 310

    Non-binding Guidance: A Recall Readiness Rundown and Recent FDA Actions

    May 19, 2022·22m
  311. 311

    On the Ropes: Enforcement Risk Roundtable: Argentina’s Foreign Exchange Controls and the Regulatory Risk to Companies in Argentina

    May 18, 2022·33m
  312. 312

    Impacts of the Russia/Ukraine Conflict on ETFs

    May 13, 2022·9m
  313. 313

    Co-Investments and Fund Recapitalizations

    May 3, 2022·6m
  314. 314

    Talkin' Trade: Enforcement of Section 337 Exclusion Orders at U.S. Customs and Border Protection

    Apr 7, 2022·25m
  315. 315

    A Primer on Asset-backed Leverage Facilities

    Mar 31, 2022·14m
  316. 316

    Non-binding Guidance: Real-World Evidence in Drug Development

    Mar 30, 2022·18m
  317. 317

    A Primer on Fund Recapitalizations

    Mar 30, 2022·11m
  318. 318

    ERISA Litigation Update: Revisiting Northwestern University and Intel

    Mar 24, 2022·26m
  319. 319

    Women @ RopesTalk: Conversation with Jennifer Wilen, Bombas

    Mar 24, 2022·27m
  320. 320

    On the Ropes: Enforcement Risk Roundtable: Anti-Corruption and International Risk Perspectives from Recent Developments in Sweden

    Mar 15, 2022·22m
  321. 321

    Recent Developments on the Use of MAC Clauses In Secondary Transactions

    Mar 3, 2022·9m
  322. 322

    Alumni @ RopesTalk: Conversation with Ryan Dickey, DOJ & GW Law

    Mar 3, 2022·21m
  323. 323

    Talkin' Trade: The Powerful General Exclusion Order

    Feb 23, 2022·26m
  324. 324

    Women @ RopesTalk: Conversation with Adela Cepeda (Mercer Funds) & Susan Rhee (Jackson National Asset Management)

    Feb 16, 2022·38m
  325. 325

    On the Ropes: Enforcement Risk Roundtable: Anti-Corruption and International Risk Perspectives from Recent Developments in France

    Feb 15, 2022·20m
  326. 326

    Private Fund Regulatory Update: Recent Developments Regarding Management Fee Calculation and Electronic Communications

    Jan 24, 2022·19m
  327. 327

    Women @ RopesTalk: Conversation with Ingrid Zhang, Novartis Pharmaceuticals

    Jan 19, 2022·25m
  328. 328

    How Would an ESG-Friendly DOL Final Rule Change the Investment Marketplace for ERISA Plans?

    Jan 18, 2022·24m
  329. 329

    Perspectives on the 2021 Secondaries Market and What May Lie Ahead in 2022

    Jan 12, 2022·14m
  330. 330

    Non-binding Guidance: Recent Developments in FDA Inspection Policy and Implications for Drug and Device Manufacturers

    Jan 6, 2022·23m
  331. 331

    Talkin' Trade: What Remedies Can The International Trade Commission Impose?

    Jan 5, 2022·25m
  332. 332

    The Rise of ESG-linked Debt

    Dec 16, 2021·23m
  333. 333

    Women @ RopesTalk: Conversation with Anne Garcia, The Ohio State University

    Dec 1, 2021·39m
  334. 334

    Talkin' Trade: Who’s Adjudicating Section 337 Investigations?

    Nov 30, 2021·24m
  335. 335

    The DOL’s About-face on ESG for ERISA Plan Fiduciary Investment Decision-making

    Nov 22, 2021·18m
  336. 336

    Health Care Compliance Check-up: Belgium

    Nov 18, 2021·17m
  337. 337

    Non-binding Guidance: Rolling Back the Medicare Coverage of Innovative Technology (MCIT) Rule

    Nov 8, 2021·17m
  338. 338

    Talkin’ Trade: When Section 101 Meets Section 337

    Oct 25, 2021·29m
  339. 339

    Alumni @ RopesTalk: Conversation with Julie Constable, Blackstone

    Oct 20, 2021·17m
  340. 340

    Health Care Compliance Check-up: Mexico

    Oct 18, 2021·19m
  341. 341

    Decoding Digital Health: Recent Developments in AI and Machine Learning for Life Sciences and Health Care

    Oct 12, 2021·28m
  342. 342

    Compliance & Risk Management: Conversation with Jerry Kral, Brown-Forman

    Oct 8, 2021·11m
  343. 343

    Women @ RopesTalk: Conversation with Kim McCaslin, Bain Capital

    Oct 5, 2021·24m
  344. 344

    Recent ERISA Litigation Trends & Outcomes

    Sep 22, 2021·22m
  345. 345

    Non-binding Guidance: FDA’s Intended Use Final Rule

    Sep 21, 2021·24m
  346. 346

    Health Care Compliance Check-up: Netherlands

    Sep 8, 2021·18m
  347. 347

    Talkin' Trade: The Interplay Between the ITC and the PTAB

    Sep 1, 2021·34m
  348. 348

    Conductive Discussions: Patent Eligibility Under Section 101

    Aug 12, 2021·18m
  349. 349

    Fraud in the Subscription Facility Market: Lenders’ Response

    Aug 11, 2021·8m
  350. 350

    Health Care Compliance Check-up: Brazil

    Aug 5, 2021·25m
  351. 351

    Fundraising Update: Secondaries Funds

    Aug 4, 2021·5m
  352. 352

    Non-binding Guidance: COVID-19 Vaccine Mandate Litigation

    Jul 29, 2021·26m
  353. 353

    The U.S. Supreme Court Agrees to Hear the Northwestern University Retirement Plan Fee Lawsuit

    Jul 23, 2021·16m
  354. 354

    Talkin' Trade: IMPORTant Information!

    Jul 22, 2021·25m
  355. 355

    Women @ RopesTalk: Conversation with Cari Robinson, Revlon

    Jul 21, 2021·29m
  356. 356

    Life Sciences Real Estate Market Trends: Conversation with Joe Marconi, Bain Capital Real Estate

    Jul 9, 2021·29m
  357. 357

    Health Care Compliance Check-up: Czech Republic

    Jul 1, 2021·27m
  358. 358

    Conductive Discussions: Arbitration—Customizable Dispute Resolution

    Jun 29, 2021·20m
  359. 359

    Pooled Employer Plans (“PEPs”)—An Outsourcing Opportunity for Small and Larger Employers as well as Private Equity Sponsors to Reduce their ERISA Fiduciary Responsibilities

    Jun 25, 2021·15m
  360. 360

    Navigating the “New Normal” for Security-Based Swaps: Buy-Side Considerations for the SEC’s Security-Based Swap Rules

    Jun 17, 2021·16m
  361. 361

    Women @ RopesTalk: Conversation with Cris Rothfuss, Sarepta Therapeutics

    Jun 16, 2021·31m
  362. 362

    Talkin' Trade: Demystifying the Domestic Industry Requirement

    Jun 15, 2021·17m
  363. 363

    Rated Note Feeder Structures

    Jun 7, 2021·10m
  364. 364

    Non-binding Guidance: The Defense Production Act and the COVID-19 Pandemic

    May 27, 2021·19m
  365. 365

    Digital Assets: An Emerging Opportunity for Registered Funds

    May 25, 2021·14m
  366. 366

    Decoding Digital Health: 2021 Developing Trends and Hot Topics in Digital Health

    May 19, 2021·21m
  367. 367

    Talkin' Trade: Introduction to Section 337 and the ITC

    May 18, 2021·18m
  368. 368

    The Rise of ESG ETFs

    May 13, 2021·14m
  369. 369

    Women @ RopesTalk: Conversation with Tamarah Belczyk, Audax Group

    May 12, 2021·25m
  370. 370

    The DOL’s Cybersecurity Guidance for Retirement Plan Sponsors, Service Providers and Participants

    May 11, 2021·23m
  371. 371

    Conductive Discussions: Cybersecurity Threats to the Chip Industry

    May 10, 2021·11m
  372. 372

    Co-Investments in the Age of Fund Recapitalizations

    May 7, 2021·6m
  373. 373

    LIBOR Cessation Update

    May 6, 2021·13m
  374. 374

    Non-binding Guidance: European Life Sciences Regulatory Trends with Dr. Lincoln Tsang

    Apr 28, 2021·24m
  375. 375

    Data, Privacy and Cybersecurity Under the Biden-Harris Administration

    Apr 22, 2021·25m
  376. 376

    Anderson v. Intel—A Test Case Regarding the Prudence of Adding Alternative Investments to Defined Contribution Plan Menus

    Apr 15, 2021·8m
  377. 377

    On the Ropes: Enforcement Risk Roundtable: Anti-Corruption and International Risk Perspectives from Recent Developments in Poland

    Apr 15, 2021·12m
  378. 378

    On the Ropes: Enforcement Risk Roundtable: Anti-Corruption and International Risk Perspectives from Recent Developments in Poland

    Apr 15, 2021·12m
  379. 379

    Private Fund Regulatory Update: 2021 SEC Enforcement Priorities

    Apr 14, 2021·17m
  380. 380

    Conductive Discussions: CFIUS, Trade Regulations, and the Impact on the Semiconductor Industry

    Apr 13, 2021·13m
  381. 381

    Women @ RopesTalk: Conversation with Shana Cappell, PepsiCo

    Apr 13, 2021·25m
  382. 382

    Fraud in the Subscription Facility Market: Will Anything Change?

    Apr 13, 2021·13m
  383. 383

    Creating a Competitive Advantage Through Long-Term Ownership

    Apr 7, 2021·7m
  384. 384

    Do Fund Sponsors Need a Secondary Buyer for a Fund Recap?

    Apr 6, 2021·5m
  385. 385

    2021 DOJ Enforcement Priorities Under U.S. Attorney General Merrick Garland

    Mar 26, 2021·18m
  386. 386

    Recent Developments in European Restructuring Regimes

    Mar 26, 2021·28m
  387. 387

    CMMI Program Delays and Suspensions—Recommended Next Steps

    Mar 18, 2021·16m
  388. 388

    The Evolving Regulatory Landscape for ERISA Plan Fiduciaries—Cybersecurity Concerns for Plan Sponsors

    Mar 16, 2021·18m
  389. 389

    Conductive Discussions: Patent Infringement Under 271(g)—Tips, Traps, and Trends

    Mar 15, 2021·21m
  390. 390

    On the Ropes: Enforcement Risk Roundtable: Anti-Corruption Developments in Ghana

    Mar 10, 2021·10m
  391. 391

    Non-binding Guidance: FDA Regulatory Developments in AI and Machine Learning

    Mar 3, 2021·18m
  392. 392

    Conductive Discussions: Trade Secret Theft—Trends, Remedies, and Trolls, Oh My!

    Feb 17, 2021·15m
  393. 393

    Considerations for Potential New Entrants into the ETF Market

    Feb 16, 2021·13m
  394. 394

    Communist Chinese Military Companies Executive Order: Implications and Key Questions

    Feb 11, 2021·16m
  395. 395

    Newly-Finalized ECI Withholding Regulations: Implications for the Secondaries Market in 2021

    Feb 9, 2021·10m
  396. 396

    The Evolving Regulatory Landscape for ERISA Plan Fiduciaries—The Biden Administration & ESG and Proxy Voting Rules

    Feb 9, 2021·23m
  397. 397

    Operating Under the ETF Rule: How Are Things Going in the Early Days?

    Feb 1, 2021·13m
  398. 398

    Culture & Compliance Chronicles: Compliance Analytics Simplified (A Chat with Integrity Tech Leaders from Lextegrity, Part II)

    Jan 27, 2021·29m
  399. 399

    2020 Secondary Market in Review

    Jan 25, 2021·11m
  400. 400

    Women @ RopesTalk: Conversation with Jane Appleby, Advocate Aurora Health

    Jan 19, 2021·30m
  401. 401

    2021 Global Anti-Corruption Update

    Jan 14, 2021·6m
  402. 402

    Recent Trends in COVID-19 Employment Litigation

    Jan 13, 2021·9m
  403. 403

    Pandemic Fundraising Insights and What Lies Ahead for Private Equity in 2021: Conversation with Tom Burger, Gridiron Capital

    Jan 7, 2021·13m
  404. 404

    End of Life Fund Issues

    Jan 6, 2021·6m
  405. 405

    Mutual Fund to ETF Conversion

    Jan 5, 2021·18m
  406. 406

    ESG: Integrating EU and DOL Requirements

    Dec 16, 2020·21m
  407. 407

    Fund-of-Funds Final Rule & Its Impact on ETFs

    Dec 15, 2020·15m
  408. 408

    Alumni @ RopesTalk: Conversation with Jacob Comer, NovaQuest Capital Management

    Dec 14, 2020·27m
  409. 409

    Recent FCA Statement on GDPR Compliance

    Dec 14, 2020·6m
  410. 410

    Rep and Warranty Insurance in the Context of Fund Recapitalizations: Considerations for Both Fund Sponsors and Investors

    Dec 10, 2020·8m
  411. 411

    Culture & Compliance Chronicles: Compliance Analytics Simplified (A Chat with Integrity Tech Leaders from Lextegrity, Part I)

    Dec 1, 2020·25m
  412. 412

    Women @ RopesTalk: Conversation with Ilana Kukoff, Cognition Builders

    Nov 18, 2020·26m
  413. 413

    What's Happening Now: Current Developments for ETFs as the ETF Rule’s Compliance Date Approaches

    Nov 11, 2020·26m
  414. 414

    Single Asset Recapitalizations: Considerations for Both Fund Sponsors and Investors

    Nov 9, 2020·11m
  415. 415

    Cryptocurrency Custody Considerations

    Nov 2, 2020·12m
  416. 416

    Women @ RopesTalk: Conversation with Louise Dumican, The Carlyle Group

    Oct 14, 2020·26m
  417. 417

    SEC Updates to the Accredited Investor and Qualified Institutional Buyer Definitions

    Oct 6, 2020·11m
  418. 418

    On the Ropes: Enforcement Risk Roundtable: Introduction

    Oct 6, 2020·3m
  419. 419

    Non-binding Guidance: Real-World Evidence in Drug Development and the Impact of the COVID-19 Pandemic

    Sep 30, 2020·18m
  420. 420

    Credit Funds: Operating Side-by-Side Open- and Closed-End Private Fund Structures

    Sep 16, 2020·10m
  421. 421

    Culture & Compliance Chronicles: Using Data Ethically

    Sep 14, 2020·16m
  422. 422

    Culture & Compliance Chronicles: Navigating Data Privacy

    Aug 25, 2020·27m
  423. 423

    Credit Funds: Fundraising and Restructuring in the COVID-19 Environment: U.S. v. Europe

    Aug 20, 2020·23m
  424. 424

    CFIUS Considerations for Credit Funds

    Aug 13, 2020·15m
  425. 425

    Culture & Compliance Chronicles: Techniques on Approaching & Establishing Relationships

    Aug 6, 2020·27m
  426. 426

    U.S. Anti-Money Laundering Compliance Considerations for Fund Sponsors

    Aug 5, 2020·16m
  427. 427

    ICI Memo: LIBOR Update – SEC OCIE Issues Risk Alert on LIBOR Transition Preparedness

    Aug 3, 2020·10m
  428. 428

    Introduction to Gender-Lens Investing

    Jul 30, 2020·6m
  429. 429

    Rethinking the “S” in ESG in Light of the COVID-19 Pandemic

    Jul 23, 2020·6m
  430. 430

    SEC Issues Risk Alert: Compliance Issues for Investment Advisers Managing Private Funds – What You Need to Know

    Jul 22, 2020·18m
  431. 431

    Non-binding Guidance: FDA Regulation of COVID-19 Diagnostic Tests and “Return to Work”

    Jul 21, 2020·24m
  432. 432

    Market Declines and Falling Out of Carry: Considerations for Fund Sponsors and Investors

    Jul 17, 2020·6m
  433. 433

    Culture & Compliance Chronicles: Building Relationships & Making Connections

    Jul 16, 2020·23m
  434. 434

    Insiders' Perspectives on the Ins and Outs of the 2020 DOJ FCPA Guide: A Conversation with Ropes & Gray’s Anti-Corruption and International Risk Leaders

    Jul 15, 2020·33m
  435. 435

    Culture & Compliance Chronicles: Effective Remediation

    Jul 1, 2020·23m
  436. 436

    Culture & Compliance Chronicles: Measuring Culture

    Jun 15, 2020·32m
  437. 437

    Global Health Care Compliance Initiative: Managing Compliance Issues and Process Changes Related to COVID-19

    Jun 4, 2020·14m
  438. 438

    Alumni @ RopesTalk: Conversation with Jason Idilbi, Passport

    Jun 3, 2020·28m
  439. 439

    Culture & Compliance Chronicles: Culture in Times of Crisis

    Jun 1, 2020·32m
  440. 440

    ESG Considerations for Asset Managers in Light of the COVID-19 Pandemic

    May 18, 2020·5m
  441. 441

    Credit Funds: Considerations for Credit Fund Managers Overseeing ERISA Plan Assets in Light of the COVID-19 Pandemic

    May 13, 2020·16m
  442. 442

    The Intersection of Private and Registered Funds: Interval Fund Investments in Private Open-End Real Estate Funds

    May 12, 2020·27m
  443. 443

    Preferred Equity Financings: Tools for Both Fund Sponsors and Investors

    May 7, 2020·6m
  444. 444

    Building a Sanctions Compliance Programme

    Apr 28, 2020·51m
  445. 445

    Culture & Compliance Chronicles: Incorporating Behavioral Science in Audit & Monitoring

    Apr 28, 2020·17m
  446. 446

    Proposed Amendments to the Volcker Rule's Covered Fund Provisions

    Apr 27, 2020·11m
  447. 447

    TALF 2.0: Anticipating the 2020 Term Asset-Backed Securities Loan Facility Program

    Apr 20, 2020·9m
  448. 448

    Recent Developments in Credit Funds Secondaries: Has the COVID-19 Pandemic Introduced New Opportunities?

    Apr 15, 2020·4m
  449. 449

    Culture & Compliance Chronicles: Behavioral Science—The Audit & Monitoring Perspective

    Apr 2, 2020·27m
  450. 450

    Key Decisions for Defined Contribution Plan Sponsors Under the CARES Act

    Apr 1, 2020·11m
  451. 451

    Cross-selling in the Crosshairs: Implications and Challenges of the Oracle 401(k) Fee Litigation Settlement

    Mar 23, 2020·8m
  452. 452

    Alumni @ RopesTalk: Conversation with Alex Roberts, UNH Law

    Mar 18, 2020·28m
  453. 453

    COVID-19 and Derivatives Trading Agreements: Considerations for the Buy-Side

    Mar 16, 2020·8m
  454. 454

    CFIUS Update: Key Takeaways from the FIRRMA Implementing Regulations

    Mar 5, 2020·12m
  455. 455

    ACES Compliance Summit: Conversation with Momentum Events

    Feb 14, 2020·12m
  456. 456

    Questions & Concerns About Documentation: A Conversation with Colin Adams, M3 Partners

    Feb 12, 2020·27m
  457. 457

    Alumni @ RopesTalk: Conversation with Jennifer Bealer, Progyny

    Feb 12, 2020·16m
  458. 458

    ESMA Report: Undue Pressure on Companies

    Jan 27, 2020·5m
  459. 459

    Non-binding Guidance: SEC Disclosure Issues for Life Sciences Companies

    Jan 9, 2020·13m
  460. 460

    CFTC Issues LIBOR Transition Relief for Swaps

    Jan 6, 2020·6m
  461. 461

    Culture & Compliance Chronicles: Applying Behavioral Science to Compliance—A Conversation with Richard Bistrong, Front-Line Anti-Bribery LLC

    Dec 18, 2019·1h 1m
  462. 462

    ERISA Plan Fiduciaries’ Proxy Voting: Regulatory Updates

    Dec 16, 2019·8m
  463. 463

    CFIUS: Recent Regulatory Developments

    Dec 2, 2019·20m
  464. 464

    Supreme Court May Resolve Key ERISA Statute of Limitations and Proprietary Fund Litigation Questions

    Nov 25, 2019·12m
  465. 465

    Key ESG Considerations for Family Offices and Foundations

    Nov 18, 2019·10m
  466. 466

    Credit Funds: Hot Topics in BDC Regulation

    Nov 18, 2019·9m
  467. 467

    Credit Funds: Compliance Considerations for Valuation

    Nov 13, 2019·11m
  468. 468

    Non-binding Guidance: A Discussion of Kisor v. Wilkie

    Nov 12, 2019·27m
  469. 469

    Credit Funds: Credit Default Swaps in the Distressed Limelight

    Nov 11, 2019·12m
  470. 470

    Private Funds Update: The UK Stewardship Code 2020

    Nov 11, 2019·5m
  471. 471

    Alumni @ RopesTalk: Conversation with Sabrina Ross, Uber

    Oct 25, 2019·23m
  472. 472

    Fund Subscription Facilities: Key Considerations for Limited Partners

    Sep 24, 2019·10m
  473. 473

    Asset Management Regulatory Update: Reg BI, Form CRS, and SEC’s Fiduciary Duty Interpretation

    Sep 19, 2019·18m
  474. 474

    Non-binding Guidance: Breakthrough Devices Program

    Sep 12, 2019·16m
  475. 475

    Non-binding Guidance: Expedited Review Programs for Drugs and Biologics

    Sep 5, 2019·13m
  476. 476

    Federal Court Rejects Mutual Fund Fee Claims and Recognizes Market Realities

    Sep 4, 2019·11m
  477. 477

    Non-binding Guidance: Real-World Evidence in Drug Development and FDA Submissions

    Aug 12, 2019·16m
  478. 478

    Private Fund Regulatory Update: Network and Cloud Storage

    Jul 22, 2019·7m
  479. 479

    European Green Finance and Sustainability Proposals: Impact for Asset Managers

    Jul 18, 2019·8m
  480. 480

    Non-binding Guidance: Examining FDA’s Enforcement Authority Over Stem Cell Clinics and Compounders

    Jun 28, 2019·25m
  481. 481

    Alumni @ RopesTalk: Conversation with Jeff Gleason, Delaware North

    Jun 18, 2019·19m
  482. 482

    Credit Funds: Replacing LIBOR – Steps To Consider Taking Now

    Jun 10, 2019·13m
  483. 483

    The PEP Talk: General Solicitation by Private Equity Funds Under 506(c)

    Jun 3, 2019·11m
  484. 484

    International Finance Corporation (IFC) Impact Investing Standards

    May 22, 2019·6m
  485. 485

    ERISA Plan Sponsors, ESG and the April 2019 Executive Order on Promoting Energy Infrastructure

    May 10, 2019·7m
  486. 486

    Visibility Counts: Corporate Guidelines for LGBT+ Self-ID

    May 6, 2019·23m
  487. 487

    Non-binding Guidance: Former FDA Commissioner Scott Gottlieb’s Unfinished Business

    May 2, 2019·23m
  488. 488

    Credit Funds: 1940 Act Interval Funds

    May 1, 2019·10m
  489. 489

    Non-binding Guidance: FDA’s Regulation of Products Containing CBD

    Mar 29, 2019·17m
  490. 490

    Private Fund Regulatory Update: Post-U.S. Government Shutdown

    Mar 19, 2019·20m
  491. 491

    Conductive Discussions: Recent FRAND & Trade Secret Enforcement Trends Affecting the Semiconductor Industry

    Jan 24, 2019·22m
  492. 492

    Keeping Up with Recent Changes and Trends in Private Fund Regulation

    Jan 17, 2019·28m
  493. 493

    Introduction to Credit Funds: Basics on How Credit Funds and Private Equity Funds Differ

    Sep 27, 2018·11m
  494. 494

    Credit Funds: The Benefits, Challenges and Applications of Treaty Fund Structures When Investing in Credit

    Sep 20, 2018·22m
  495. 495

    International Risks Facing Latin America Companies

    Aug 13, 2018·24m
  496. 496

    Common Risks and Challenges in Running a Global Ethics & Compliance Program

    Jun 19, 2018·17m
  497. 497

    Credit Funds: What Managers Need to Know and Practical Tips to Avoid Insider Trading Risks

    Jun 5, 2018·14m
  498. 498

    Credit Funds: How PE Funds Can Address and Minimize Conflict When Expanding Into Credit

    May 1, 2018·13m
  499. 499

    Risk Management: Troubleshooting & Problem Solving

    Apr 23, 2018·8m
  500. 500

    New Unrelated Business Taxable Income Liability for Providing Certain Fringe Benefits

    Apr 19, 2018·17m